Wednesday, July 23, 2014 11:55:09 PM
2) If the sequence is identical to KBLB's Monster Silk(TM) that in and of itself is proof positive that the silk was stolen (unless the persons or corporations having possession of the silk can provide a chain of purchase from KBLB.)
3) If the sequence is very similar but not identical (as from process duplication) then that is in and of itself proof positive of patent infringement.
There are no "Holder in good conscience" rights in such cases.
Any person or corporation holding stolen goods is at the minimum required to return the goods to the rightful owner with no recompense.
They may be additionally liable for up to treble punitive damages under tort law and also criminally liable if they had any knowledge of the theft.
Similarly harsh penalties are imposed for patent and copyright infringement.
And don't even try to give me your old saw about how really big corporations with really low morals can hire lots of lawyers and out spend you to win the case.
Kimberley Thompson, the CEO of KBLB who you so love to disparage was and is an intellectual property lawyer who specialized in taking really big companies with really low morals to court over patent and IP issues and collecting HUGE judgments against them!
This is in fact how he initially financed KBLB.
Please remember that these laws would not only apply to the 23 year old Chinese kid who was responsible for the initial theft.
They are applied equally to any corporation down the line who attempts to make a profit by selling tainted goods.
Mike L.
Recent KBLB News
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 11/22/2023 09:31:54 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/16/2023 09:30:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:43:51 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 09/11/2023 08:30:50 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 09/08/2023 04:15:15 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 09/01/2023 08:30:52 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 08:35:05 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM